Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Aircraft Weapons Market

ID: MRFR/AD/19307-HCR
100 Pages
Abbas Raut
Last Updated: April 06, 2026

US Aircraft Weapons Market Size, Share, Industry Trend & Analysis Research Report: By Guidance System (GPS-Guided Weapons, Laser-Guided Weapons, Inertial-Guided Weapons, Autonomous Weapons, Others), By Aircraft Type (Fixed-Wing Aircraft, Rotary-Wing Aircraft, Unmanned Aerial Vehicles (UAVs)), By Range (Short-Range Weapons, Medium-Range Weapons, Long-Range Weapons), By Weapon Type (Air-to-Air Weapons, Air-to-Ground Weapons, Anti-Ship Weapons, Countermeasures) andBy End Use (Military, Army, Navy, Civilian, Law Enforcement, Security Agencies)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Aircraft Weapons Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Life Sciences, BY Guidance System (USD Million)
  49.     4.1.1 GPS-Guided Weapons
  50.     4.1.2 Laser-Guided Weapons
  51.     4.1.3 Inertial-Guided Weapons
  52.     4.1.4 Autonomous Weapons
  53.     4.1.5 Others
  54.   4.2 Life Sciences, BY Aircraft Type (USD Million)
  55.     4.2.1 Fixed-Wing Aircraft
  56.     4.2.2 Rotary-Wing Aircraft
  57.     4.2.3 Unmanned Aerial Vehicles (UAVs)
  58.   4.3 Life Sciences, BY Range (USD Million)
  59.     4.3.1 Short-Range Weapons
  60.     4.3.2 Medium-Range Weapons
  61.     4.3.3 Long-Range Weapons
  62.   4.4 Life Sciences, BY Weapon Type (USD Million)
  63.     4.4.1 Air-To-Air Weapons
  64.     4.4.2 Air-To-Ground Weapons
  65.     4.4.3 Anti-Ship Weapons
  66.     4.4.4 Countermeasures
  67.   4.5 Life Sciences, BY End Use (USD Million)
  68.     4.5.1 Military
  69.     4.5.2 Army
  70.     4.5.3 Navy
  71.     4.5.4 Civilian
  72.     4.5.5 Law Enforcement
  73.     4.5.6 Security Agencies
  74. 5 SECTION V: COMPETITIVE ANALYSIS
  75.   5.1 Competitive Landscape
  76.     5.1.1 Overview
  77.     5.1.2 Competitive Analysis
  78.     5.1.3 Market share Analysis
  79.     5.1.4 Major Growth Strategy in the Life Sciences
  80.     5.1.5 Competitive Benchmarking
  81.     5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  82.     5.1.7 Key developments and growth strategies
  83.       5.1.7.1 New Product Launch/Service Deployment
  84.       5.1.7.2 Merger & Acquisitions
  85.       5.1.7.3 Joint Ventures
  86.     5.1.8 Major Players Financial Matrix
  87.       5.1.8.1 Sales and Operating Income
  88.       5.1.8.2 Major Players R&D Expenditure. 2023
  89.   5.2 Company Profiles
  90.     5.2.1 Lockheed Martin (US)
  91.       5.2.1.1 Financial Overview
  92.       5.2.1.2 Products Offered
  93.       5.2.1.3 Key Developments
  94.       5.2.1.4 SWOT Analysis
  95.       5.2.1.5 Key Strategies
  96.     5.2.2 Northrop Grumman (US)
  97.       5.2.2.1 Financial Overview
  98.       5.2.2.2 Products Offered
  99.       5.2.2.3 Key Developments
  100.       5.2.2.4 SWOT Analysis
  101.       5.2.2.5 Key Strategies
  102.     5.2.3 Raytheon Technologies (US)
  103.       5.2.3.1 Financial Overview
  104.       5.2.3.2 Products Offered
  105.       5.2.3.3 Key Developments
  106.       5.2.3.4 SWOT Analysis
  107.       5.2.3.5 Key Strategies
  108.     5.2.4 BAE Systems (GB)
  109.       5.2.4.1 Financial Overview
  110.       5.2.4.2 Products Offered
  111.       5.2.4.3 Key Developments
  112.       5.2.4.4 SWOT Analysis
  113.       5.2.4.5 Key Strategies
  114.     5.2.5 General Dynamics (US)
  115.       5.2.5.1 Financial Overview
  116.       5.2.5.2 Products Offered
  117.       5.2.5.3 Key Developments
  118.       5.2.5.4 SWOT Analysis
  119.       5.2.5.5 Key Strategies
  120.     5.2.6 Thales Group (FR)
  121.       5.2.6.1 Financial Overview
  122.       5.2.6.2 Products Offered
  123.       5.2.6.3 Key Developments
  124.       5.2.6.4 SWOT Analysis
  125.       5.2.6.5 Key Strategies
  126.     5.2.7 Leonardo (IT)
  127.       5.2.7.1 Financial Overview
  128.       5.2.7.2 Products Offered
  129.       5.2.7.3 Key Developments
  130.       5.2.7.4 SWOT Analysis
  131.       5.2.7.5 Key Strategies
  132.     5.2.8 Rheinmetall (DE)
  133.       5.2.8.1 Financial Overview
  134.       5.2.8.2 Products Offered
  135.       5.2.8.3 Key Developments
  136.       5.2.8.4 SWOT Analysis
  137.       5.2.8.5 Key Strategies
  138.     5.2.9 Saab (SE)
  139.       5.2.9.1 Financial Overview
  140.       5.2.9.2 Products Offered
  141.       5.2.9.3 Key Developments
  142.       5.2.9.4 SWOT Analysis
  143.       5.2.9.5 Key Strategies
  144.   5.3 Appendix
  145.     5.3.1 References
  146.     5.3.2 Related Reports
  147. 6 LIST OF FIGURES
  148.   6.1 MARKET SYNOPSIS
  149.   6.2 US MARKET ANALYSIS BY GUIDANCE SYSTEM
  150.   6.3 US MARKET ANALYSIS BY AIRCRAFT TYPE
  151.   6.4 US MARKET ANALYSIS BY RANGE
  152.   6.5 US MARKET ANALYSIS BY WEAPON TYPE
  153.   6.6 US MARKET ANALYSIS BY END USE
  154.   6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
  155.   6.8 RESEARCH PROCESS OF MRFR
  156.   6.9 DRO ANALYSIS OF LIFE SCIENCES
  157.   6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
  158.   6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
  159.   6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
  160.   6.13 LIFE SCIENCES, BY GUIDANCE SYSTEM, 2024 (% SHARE)
  161.   6.14 LIFE SCIENCES, BY GUIDANCE SYSTEM, 2024 TO 2035 (USD Million)
  162.   6.15 LIFE SCIENCES, BY AIRCRAFT TYPE, 2024 (% SHARE)
  163.   6.16 LIFE SCIENCES, BY AIRCRAFT TYPE, 2024 TO 2035 (USD Million)
  164.   6.17 LIFE SCIENCES, BY RANGE, 2024 (% SHARE)
  165.   6.18 LIFE SCIENCES, BY RANGE, 2024 TO 2035 (USD Million)
  166.   6.19 LIFE SCIENCES, BY WEAPON TYPE, 2024 (% SHARE)
  167.   6.20 LIFE SCIENCES, BY WEAPON TYPE, 2024 TO 2035 (USD Million)
  168.   6.21 LIFE SCIENCES, BY END USE, 2024 (% SHARE)
  169.   6.22 LIFE SCIENCES, BY END USE, 2024 TO 2035 (USD Million)
  170.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  171. 7 LIST OF TABLES
  172.   7.1 LIST OF ASSUMPTIONS
  173.     7.1.1
  174.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  175.     7.2.1 BY GUIDANCE SYSTEM, 2025-2035 (USD Million)
  176.     7.2.2 BY AIRCRAFT TYPE, 2025-2035 (USD Million)
  177.     7.2.3 BY RANGE, 2025-2035 (USD Million)
  178.     7.2.4 BY WEAPON TYPE, 2025-2035 (USD Million)
  179.     7.2.5 BY END USE, 2025-2035 (USD Million)
  180.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  181.     7.3.1
  182.   7.4 ACQUISITION/PARTNERSHIP
  183.     7.4.1

US Life Sciences Market Segmentation

Life Sciences By Guidance System (USD Million, 2025-2035)

  • GPS-Guided Weapons
  • Laser-Guided Weapons
  • Inertial-Guided Weapons
  • Autonomous Weapons
  • Others

Life Sciences By Aircraft Type (USD Million, 2025-2035)

  • Fixed-Wing Aircraft
  • Rotary-Wing Aircraft
  • Unmanned Aerial Vehicles (UAVs)

Life Sciences By Range (USD Million, 2025-2035)

  • Short-Range Weapons
  • Medium-Range Weapons
  • Long-Range Weapons

Life Sciences By Weapon Type (USD Million, 2025-2035)

  • Air-To-Air Weapons
  • Air-To-Ground Weapons
  • Anti-Ship Weapons
  • Countermeasures

Life Sciences By End Use (USD Million, 2025-2035)

  • Military
  • Army
  • Navy
  • Civilian
  • Law Enforcement
  • Security Agencies

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions